CRISPR Therapeutics AG (CRSP) Is A Buy According To Analysts
CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.71 and has seen 0.52 million shares traded in the recent trading session. The company, currently
CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.71 and has seen 0.52 million shares traded in the recent trading session. The company, currently
908 Devices Inc (NASDAQ:MASS) has a beta value of 0.20 and has seen 0.66 million shares traded in the recent trading session. The company, currently
CARGO Therapeutics Inc (NASDAQ:CRGX) has a beta value of -0.12 and has seen 1.07 million shares traded in the recent trading session. The company, currently
Advanced Micro Devices Inc (NASDAQ:AMD) has a beta value of 1.97 and has seen 7.78 million shares traded in the recent trading session. The company,
Element Solutions Inc (NYSE:ESI) has a beta value of 1.30 and has seen 2.13 million shares traded in the recent trading session. The company, currently
Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) has a beta value of 2.06 and has seen 2.24 million shares traded in the recent trading session. The
Lam Research Corp (NASDAQ:LRCX) has a beta value of 1.66 and has seen 2.08 million shares traded in the recent trading session. The company, currently
Permian Resources Corp (NYSE:PR) has a beta value of 1.25 and has seen 1.15 million shares traded in the recent trading session. The company, currently
Macy’s Inc (NYSE:M) has a beta value of 1.78 and has seen 0.74 million shares traded in the recent trading session. The company, currently valued
KKR & Co. Inc (NYSE:KKR) has a beta value of 1.92 and has seen 0.7 million shares traded in the recent trading session. The company,
© 2024, Powered by Smart TechOne